期刊
MOLECULAR GENETICS & GENOMIC MEDICINE
卷 3, 期 2, 页码 111-120出版社
WILEY
DOI: 10.1002/mgg3.117
关键词
Albright hereditary osteodystrophy; G proteins; genotype-phenotype correlation; GNAS; Gsa; mutation; pseudohypoparathyroidism
资金
- German Ministry for Research and Education (BMBF) [GMG 01GM0315]
- Novo Nordisk Pharma from the University of Lubeck
- Cluster of Excellence
Maternally inherited inactivating GNAS mutations are the most common cause of parathyroid hormone (PTH) resistance and Albright hereditary osteodystrophy (AHO) leading to pseudohypoparathyroidism type Ia (PHPIa) due to Gsa deficiency. Paternally inherited inactivating mutations lead to isolated AHO signs characterizing pseudo-pseudohypoparathyroidism (PPHP). Mutations are distributed throughout the Gsa coding exons of GNAS and there is a lack of genotype-phenotype correlation. In this study, we sequenced exon 1-13 of GNAS in a large cohort of PHPIa-and PPHP patients and identified 58 different mutations in 88 patients and 27 relatives. Thirty-three mutations including 15 missense mutations were newly discovered. Furthermore, we found three hot spots: a known hotspot (p. D190MfsX14), a second at codon 166 (p. R166C), and a third at the exon 5 acceptor splice site (c. 435 + 1G> A), found in 15, 5, and 4 unrelated patients, respectively. Comparing the clinical features to the molecular genetic data, a significantly higher occurrence of subcutaneous calcifications in patients harboring truncating versus missense mutations was demonstrated. Thus, in the largest cohort of PHPIa patients described to date, we extend the spectrum of known GNAS mutations and hot spots and demonstrate for the first time a correlation between the genetic defects and the expression of a clinical AHO-feature.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据